Blood Eosinophil Count is the Dominant Clinical Marker for type 2 Inflammatory Severity in CRSwNP

Pei‐Wen Wu,Chi‐Che Huang,Po‐Hung Chang,Ta‐Jen Lee,Yu‐Hsi Fan,Chien‐Chia Huang
DOI: https://doi.org/10.1002/lary.31899
IF: 2.97
2024-11-29
The Laryngoscope
Abstract:Blood eosinophil count (BEC) is the dominant clinical marker exhibiting the highest correlation with tissue type 2 inflammatory severity in patients with chronic rhinosinusitis and nasal polyps. Comorbid asthma, nonsmoking status, ethmoid/maxillary sinus ratio, and BEC were significant predictors of eosinophilic CRSwNP. Objective Severe type 2 eosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP) is challenging to treat and susceptible to recurrence post‐surgery. This study aimed to evaluate the relationship between clinical markers and tissue type 2 inflammatory severity in patients with CRSwNP. Methods Adult patients who underwent endoscopic sinus surgery for bilateral CRSwNP were prospectively enrolled. Tissue eosinophil count (TEC) was evaluated. Expression levels of type 2 cytokines, including IL‐5 and IL‐13, in nasal polyps were determined using real‐time PCR. Correlations between clinical markers and tissue type 2 inflammation were also assessed. Results In total, 150 participants were recruited. Ninety‐five (63.3%) exhibited type 2 eosinophilic CRSwNP defined by TEC ≥10/high power field. Weak to moderate correlations were observed between clinical and tissue markers of type 2 inflammation. Among the clinical markers, blood eosinophil count (BEC) exhibited the highest correlation with tissue type 2 inflammatory severity, as determined by TEC, IL‐5, and IL‐13 expression levels in nasal polyps. Comorbid asthma, nonsmoking status, ethmoid/maxillary sinuses (E/M) ratio, and BEC were significant predictors of eosinophilic CRSwNP in the regression analysis. Conclusions BEC, a dominant clinical marker, exhibits the highest correlation with tissue type 2 inflammatory severity, as determined by TEC, IL‐5, and IL‐13 in nasal polyps. Comorbid asthma, nonsmoking status, E/M ratio, and BEC were significant predictors of eosinophilic CRSwNP. This could help clinicians better evaluate the severity of type 2 inflammation in patients with CRSwNP and provide optimal therapeutic strategies. Level of Evidence 4 Laryngoscope, 2024
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?